Colorectal Cancer Clinical Trials in New York

Showing 41-60 of 287 trials

A Study of PHN-010 in Patients With Advanced Solid Tumors

NCT06457997

This first-in-human study will evaluate safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of PHN-010, a novel antibody-drug conjugate (ADC), in patients with advanced solid tumors.

Lung CancerColon CancerEndometrial Cancer+4 more

Pheon Therapeutics26 participantsStarted Jul 2024

Orlando, Florida, United States • Boston, Massachusetts, United States • New York, New York, United States +5 more locations

Active Not RecruitingPhase 2/3< 1 mile

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

NCT04137107

This phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer. Duloxetine increases the amount of certain chemicals in the brain that help relieve depression and pain. Giving duloxetine in patients undergoing treatment with oxaliplatin for colorectal cancer may help prevent peripheral neuropathy.

Stage II Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8

Alliance for Clinical Trials in Oncology220 participantsStarted Jun 2020

Birmingham, Alabama, United States • Mobile, Alabama, United States • Anchorage, Alaska, United States +790 more locations

A Study of PHN-010 in Patients With Advanced Solid Tumors

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Pilot Testing of a Colorectal Cancer Education Program

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Prevention of Colorectal Cancer Through Multiomics Blood Testing

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

EXoPERT EMERALD Clinical Study

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Early Onset Colorectal Cancer Detection

Other Conditions in New York